6568
S. Hachiya et al. / Tetrahedron 56 (2000) 6565±6569
(CH2Cl2/MeOH 15/1); IR (CHCl3) 1638, 1187, 1098,
973 cm21; UV±Vis (CHCl3) lmax (log e) 347 (4.79), 455
(3.77), 551 (3.94), 599 (4.62) nm; 1H NMR (CDCl3,
300 MHz) d 1.71±1.89 (m, 16H), 1.96±2.11 (m, 16H),
2.39±2.56 (m, 16H), 3.60±3.73 (m, 8H), 4.02±4.10 (m,
8H); 13C NMR (CDCl3, 75 MHz) d 18.4, 25.0, 28.9, 62.3,
99.3, 137.6, 146.4; MS (FAB) 1129 (M1H)1.
MnCl-Pz (8a). Mn(OAc)2´4H2O (50.6 mg, 0.21 mmol) and
KOH (13.2 mg, 0.24 mmol) were added to porphyrazine 7a
(0.11 g, 0.10 mmol) in DMF (3 mL) and the mixture was
heated at 1008C for 12 h. Brine (5 mL) was added, and the
mixture extracted with Et2O and CH2Cl2 (4/1, 3£30 mL).
The combined organic layers were washed with H2O
(3£20 mL) and brine (3£20 mL) and dried (Na2SO4).
Rotary evaporation and chromatography (CH2Cl2/Et2O
9/1; 19/1) gave Mn-porphyrazine 8a (106 mg, 86%) as a
dark green solid: Rf 0.26 (CH2Cl2/MeOH 19/1); IR (KBr)
1631, 1222, 1104, 1053, 970, 918, 876 cm21; UV±Vis
(CHCl3) lmax (log e) 272 (4.43), 330 (4.44), 386 (4.38),
450 (4.32), 497 (4.23), 635 (4.22) nm; MS (FAB) 1159
(M1H2Cl).1 Anal. Calcd for C56H64ClMnN8O16: C,
56.26; H, 5.40; N, 9.38. Found: C, 55.97; H, 5.17; N, 9.17.
2H-Pz (7a). AcOH (1 mL) and porphyrazine 6a (36 mg,
0.032 mmol) was stirred at 208C for 16 h, poured onto ice
and water (10 mL) and the resulting suspension brought to
pH 7 with 1 M NaOH. The precipitate was collected via
vacuum ®ltration, washed with water and chromatographed
(CHCl3) to give porphyrazine 7a (30 mg, 79%) as a blue
solid: mp .3008C (decomp.); Rf 0.65 (CH2Cl2/Et2O 4/1); IR
(CHCl3) 3313, 1662, 1619, 1216, 1185, 1103, 971, 894,
755 cm21; UV±Vis (CHCl3) lmax (log e) 338 (4.20), 427
(3.68), 554 (3.75), 632 (3.83) nm; 1H NMR (CDCl3,
300 MHz) d 23.51 (br s, 2H), 1.77±1.90 (m, 16H), 2.09
(d, J12.8 Hz, 8H), 2.21 (dd, J13.2, 4.5 Hz, 8H), 2.62 (d,
J13.3 Hz, 8H) 2.76 (dd, J12.0, 4.1 Hz, 8H), 3.72 (d,
J9.5 Hz, 8H), 4.27 (td, J10.8, 4.7 Hz, 8H); 13C NMR
(CDCl3, 75 MHz) d 18.3, 24.9, 28.9, 62.5, 100.1, 137.6,
143.3; MS (FAB) 1107 (M1H)1; HRMS (FAB) calcd for
C56H67N8O16: (M1H)1 1107.4675, found: (M1H)1
1107.4706. An X-ray crystallography determination for 7a
has already been reported,9 CCDC-100184.
MnCl-Pz (8b). The same reaction conditions as above, but
at 1208C and 3 h, gave Mn-porphyrazine 8b (0.45 g, 86%)
after chromatography (CH2Cl2/EtOAc 9/1) as a dark green
solid: Rf 0.16 (CH2Cl2/EtOAc 9/1); IR (neat) 2951, 1631,
1227, 1051, 936, 863 cm21; UV±Vis (CHCl3) lmax (log e)
230 (4.32), 330 (4.45), 388 (4.41), 448 (4.34), 491 (4.23),
633 (4.28) nm; MS (FAB) 1768 (M±H±Cl)1. Anal. Calcd
for C104H96ClMnN8O16.H2O: C, 68.55; H, 5.42; N, 6.15.
Found: C, 68.58; H, 5.51; N, 6.05.
General procedure for the epoxidation of styrene with
NaOCl
2H-Pz (7b). Propanol (15 mL), Mg (26.8 mg, 1.1 mmol)
and I2 (one small crystal) were heated to re¯ux for 12 h
under N2. The suspension was cooled and dinitrile 5b
(0.82 g, 1.92 mmol) was added and the mixture further
heated at re¯ux for 24 h. The deep blue suspension was
allowed to cool, ®ltered (Celite) and the solids washed
with CH2Cl2. Rotary evaporation and chromatography
(hexanes/CH2Cl2/EtOAc 22/10/1) gave Mg-porphyrazine
6b (0.73 g, 88%) as a dark blue solid: Rf 0.30 (hexanes/
CH2Cl2/EtOAc 22/10/1); IR (neat) 1638, 1212, 1095,
Aqueous Na2HPO4 (0.05 M; 60 mL) was added to aqueous
NaOCl (1.6 M; 20 mL) and the pH adjusted to 10.5 with
3 M HCl. An aliquot (5 mL) of this solution was added to
the porphyrazine catalyst (0.015 mmol), styrene (52 mg,
0.5 mmol), dodecane (42.6 mg, 0.25 mmol) as the internal
standard, and trioctylmethylammonium chloride (101 mg,
0.5 mmol) in CH2Cl2 (2 mL) at 08C and the mixture was
allowed to warm up to 208C. Aliquots were removed at
intervals and the formation of the styrene oxide monitored
by GC-MS. After stirring for 3 h, the mixture was extracted
with Et2O (3£20 mL) and the combined organic layers
washed with H2O (3£50 mL), brine (3£50 mL) and dried
(Na2SO4). Rotary evaporation and chromatography
(hexanes/Et2O 19:1) gave styrene oxide of which the enan-
1
969 cm21; H NMR (CDCl3, 300 MHz) d 1.72±1.90 (m,
8H), 2.16±2.25 (m, 16H), 2.30±2.44 (m, 8H) 2.80±2.93
(m, 8H), 2.93±3.14 (m, 8H), 5.39 (br d, J11.3 Hz, 8H),
7.02±7.17 (m, 40H); 13C NMR (CDCl3, 75 MHz) d 19.0,
29.0, 33.5, 73.4, 100.5, 125.9, 127.0, 127.9, 137.9, 142.6,
146.3; MS (FAB) 1738 (M1z). Porphyrazine 6b and AcOH
(20 mL) in CH2Cl2 (20 mL) were stirred at 208C for 72 h.
The solution was diluted with Et2O (50 mL), brought to pH
7.0±7.5 with 1 M NaOH and the organic layer was sepa-
rated, washed with saturated NH4Cl (3£30 mL), H2O
(3£30 mL), brine (3£25 mL) and dried (Na2SO4). Rotary
evaporation and chromatography (hexanes/CH2Cl2/EtOAc
22/10/1) gave porphyrazine 7b (0.46 g, 79%) as a blue
solid: Rf 0.28 (hexanes/CH2Cl2/EtOAc 22/10/1); IR (neat)
3309, 1665, 1621, 1504, 1453, 1264, 1216, 1162, 1096,
1048, 987, 873, 732 cm21; UV±Vis (CHCl3) lmax (log e)
338 (4.89), 429 (4.37), 553 (4.45), 632 (4.55) nm; 1H NMR
(CDCl3, 300 MHz) d 1.80±1.97 (m, 8H), 2.19±2.27 (m,
16H), 2.32±2.47 (m, 8H), 2.84±2.93 (m, 8H), 2.96±3.10,
(m, 8H), 5.38 (br d, J10.5 Hz, 8H), 7.05±7.10 (m, 24H),
7.16±7.19 (m, 16H); 13C NMR (CDCl3, 75 MHz) d 19.0,
28.9, 33.1, 73.7, 100.9, 126.1, 127.2, 128.0, 137.4, 142.1,
145.0; MS (FAB) 1718 (M12H)1. Anal. Calcd for
C104H98N8O16´H2O: C, 72.03; H, 5.81; N, 6.46. Found: C,
71.93; H, 5.81; N, 6.25.
1
tiomeric excess was determined by H NMR spectroscopy
in the presence of Eu(hfc)3 as the chiral shift reagent.20
Acknowledgements
We thank the Glaxo Group Research Ltd. for the generous
endowment (A. G. M. B.), the Wolfson Foundation for
establishing the Wolfson Centre for Organic Chemistry in
Medicinal Science at Imperial College, the Engineering and
Physical Sciences Research Council, the National Science
Foundation and NATO for generous support of our studies.
References
1. Dailey, K. K.; Yap, G. P. A.; Rheingold, A. L.; Rauchfuss, T. B.
Angew. Chem., Int. Ed. Engl. 1996, 35, 1833.
2. Bonnet, R. Chem. Soc. Rev. 1995, 19; Rosenthal, I. In